Search Results - Stephanie Downs‐Canner
- Showing 1 - 7 results of 7
-
1
-
2
-
3
Suppressive IL-17A+Foxp3+ and ex-Th17 IL-17AnegFoxp3+ Treg cells are a source of tumour-associated Treg cells by Stephanie Downs‐Canner, Sara E. Berkey, Greg M. Delgoffe, Robert P. Edwards, Tyler J. Curiel, Kunle Odunsi, David L. Bartlett, Nataša Obermajer
Published 2017Artigo -
4
-
5
-
6
Phase 1 Study of Intravenous Oncolytic Poxvirus (vvDD) in Patients With Advanced Solid Cancers by Stephanie Downs‐Canner, Zong Sheng Guo, Roshni Ravindranathan, Caroline J. Breitbach, Mark E. O’Malley, Heather Jones, Anne Moon, J. Andrea McCart, Yongli Shuai, Herbert J. Zeh, David L. Bartlett
Published 2016Artigo -
7
First-in-man Study of Western Reserve Strain Oncolytic Vaccinia Virus: Safety, Systemic Spread, and Antitumor Activity by Herbert J. Zeh, Stephanie Downs‐Canner, J. Andrea McCart, Zong Sheng Guo, Uma N. M. Rao, Lekshmi Ramalingam, Stephen H. Thorne, Heather Jones, Paweł Kaliński, Eva Wieckowski, Mark E. O’Malley, Manijeh Daneshmand, Kang Hu, John C. Bell, Tae-Ho Hwang, Anne Moon, Caroline J. Breitbach, David H. Kirn, David L. Bartlett
Published 2014Artigo
Search Tools:
Related Subjects
Biology
Medicine
Cancer
Cancer research
Cell biology
Immunology
Internal medicine
Oncology
Chemotherapy
Gene
Immune system
Immunotherapy
Oncolytic virus
Recombinant DNA
Vaccinia
Virus
Acquired immune system
Adenocarcinoma
Adverse effect
Antibody
Astrobiology
B cell
Biochemistry
Breast cancer
Clinical endpoint
Clinical trial
Context (archaeology)
FOXP3
General surgery
Genetics